Shanghai - Delayed Quote • CNY
Well Lead Medical Co., Ltd. (603309.SS)
At close: April 26 at 3:00 PM GMT+8
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
1,335,342.94
1,387,735.35
1,363,352.55
1,118,570.94
1,130,678.81
Cost of Revenue
716,147.51
750,921.39
774,497.41
644,730.73
635,953.25
Gross Profit
619,195.44
636,813.96
588,855.14
473,840.21
494,725.56
Operating Expense
382,772.93
389,891.61
373,277.37
312,987.56
263,642.11
Operating Income
236,422.51
246,922.35
215,577.77
160,852.65
231,083.44
Net Non Operating Interest Income Expense
-2,524.24
-5,941.33
-4,829.05
-7,933.67
-10,117.62
Pretax Income
227,973.41
237,302.74
205,653.01
140,223.60
190,111.53
Tax Provision
28,586.15
32,699.64
27,900.08
25,548.86
30,231.66
Net Income Common Stockholders
190,643.10
192,485.12
166,571.29
106,093.29
153,110.85
Basic EPS
0.65
0.66
0.57
0.41
0.59
Diluted EPS
0.65
0.66
0.57
0.41
0.59
Basic Average Shares
293,191.64
291,644.12
292,230.33
258,764.12
259,509.92
Diluted Average Shares
293,191.64
291,644.12
292,230.33
258,764.12
259,509.92
Total Operating Income as Reported
229,462.98
238,839.02
206,653.31
142,719.12
198,267.19
Rent Expense Supplemental
--
4,263.35
1,202.17
622.28
3,991.86
Total Expenses
1,098,920.44
1,140,813.00
1,147,774.78
957,718.29
899,595.37
Net Income from Continuing & Discontinued Operation
190,643.10
192,485.12
166,571.29
106,093.29
153,110.85
Normalized Income
203,284.59
202,473.01
180,010.86
112,263.97
163,761.67
Interest Income
3,311.22
3,670.08
3,477.27
1,376.94
904.45
Interest Expense
9,286.68
9,123.61
7,867.30
8,490.06
10,434.06
Net Interest Income
-2,524.24
-5,941.33
-4,829.05
-7,933.67
-10,117.62
EBIT
237,260.09
246,426.35
213,520.31
148,713.66
200,545.59
EBITDA
237,260.09
319,043.13
279,039.54
206,457.88
249,097.40
Reconciled Cost of Revenue
716,147.51
750,921.39
774,497.41
644,730.73
635,953.25
Reconciled Depreciation
--
72,616.78
65,519.23
57,744.22
48,551.81
Net Income from Continuing Operation Net Minority Interest
190,643.10
192,485.12
166,571.29
106,093.29
153,110.85
Total Unusual Items Excluding Goodwill
-14,453.91
-11,584.16
-15,549.05
-7,545.47
-12,664.78
Total Unusual Items
-14,453.91
-11,584.16
-15,549.05
-7,545.47
-12,664.78
Normalized EBITDA
251,714.00
330,627.29
294,588.59
214,003.35
261,762.18
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-1,812.41
-1,596.26
-2,109.47
-1,374.79
-2,013.96
12/31/2020 - 3/2/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade